by lythamcorp | Oct 31, 2024 | Reviva Pharma News
CUPERTINO, Calif., Oct. 31, 2024 — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central...
by lythamcorp | Oct 31, 2024 | Healthcare, Iradimed News
Reports record revenue of $18.3 million for the third quarter of 2024, an increase of $1.8 million or 11% over the comparable period 2023.Reports GAAP diluted EPS of $0.40 and Non-GAAP diluted EPS of $0.43 for the third quarter of 2024.Raising year end guidance on...
by lythamcorp | Oct 31, 2024 | Healthcare, InfuSystem, InfuSystem News
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. – InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient...
by lythamcorp | Oct 30, 2024 | PolyPid, PolyPid News
PETACH TIKVA, Israel, Oct. 30, 2024 — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its third quarter 2024 financial...
by lythamcorp | Oct 30, 2024 | Healthcare, Shuttle Pharmaceuticals
GAITHERSBURG, Md., Oct. 29, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer...